代謝性疾患治療の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21APR3713)
◆英語タイトル:Global Metabolic Disease Treatment Market Size, Status and Forecast 2021-2027
◆商品コード:QY21APR3713
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年4月
◆ページ数:91
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品、ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥526,500見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥789,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、代謝性疾患治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(グリコーゲン代謝疾患治療薬、脂質代謝疾患治療薬、アミノ酸代謝治療薬、その他)、用途別市場規模(病院薬局、小売薬局)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・代謝性疾患治療の市場動向
・企業の競争状況、市場シェア
・代謝性疾患治療の種類別市場規模(グリコーゲン代謝疾患治療薬、脂質代謝疾患治療薬、アミノ酸代謝治療薬、その他)
・代謝性疾患治療の用途別市場規模(病院薬局、小売薬局)
・代謝性疾患治療の北米市場規模2016-2027(アメリカ、カナダ)
・代謝性疾患治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・代謝性疾患治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・代謝性疾患治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・代謝性疾患治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Merck、Novartis、Takeda Pharmaceutical、Astra Zeneca、Beohrigher Ingelheim、KOWA、Kythera、Fuji yakuhin、LG Life Science、Metsubishi Tanabe Pharma)
・結論
【レポートの概要】

Metabolic disease mainly covers Glycogen Metabolism Disease, Lipid Metabolism Disease, Amino Acid Metabolism, Metal Metabolism Disease, etc.

Market Analysis and Insights: Global Metabolic Disease Treatment Market
The global Metabolic Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Metabolic Disease Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Metabolic Disease Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Metabolic Disease Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Metabolic Disease Treatment market.

Global Metabolic Disease Treatment Scope and Market Size
Metabolic Disease Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Metabolic Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Glycogen Metabolism Disease Drug
Lipid Metabolism Disease Drug
Amino Acid Metabolism Drug
Other

Segment by Application
Hospital Pharmacy
Retail Pharmacy

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Merck
Novartis
Takeda Pharmaceutical
Astra Zeneca
Beohrigher Ingelheim
KOWA
Kythera
Fuji yakuhin
LG Life Science

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Metabolic Disease Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Glycogen Metabolism Disease Drug
1.2.3 Lipid Metabolism Disease Drug
1.2.4 Amino Acid Metabolism Drug
1.2.5 Other
1.3 Market by Application
1.3.1 Global Metabolic Disease Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Metabolic Disease Treatment Market Perspective (2016-2027)
2.2 Metabolic Disease Treatment Growth Trends by Regions
2.2.1 Metabolic Disease Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Metabolic Disease Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Metabolic Disease Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Metabolic Disease Treatment Industry Dynamic
2.3.1 Metabolic Disease Treatment Market Trends
2.3.2 Metabolic Disease Treatment Market Drivers
2.3.3 Metabolic Disease Treatment Market Challenges
2.3.4 Metabolic Disease Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Metabolic Disease Treatment Players by Revenue
3.1.1 Global Top Metabolic Disease Treatment Players by Revenue (2016-2021)
3.1.2 Global Metabolic Disease Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Metabolic Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Metabolic Disease Treatment Revenue
3.4 Global Metabolic Disease Treatment Market Concentration Ratio
3.4.1 Global Metabolic Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Metabolic Disease Treatment Revenue in 2020
3.5 Metabolic Disease Treatment Key Players Head office and Area Served
3.6 Key Players Metabolic Disease Treatment Product Solution and Service
3.7 Date of Enter into Metabolic Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Metabolic Disease Treatment Breakdown Data by Type
4.1 Global Metabolic Disease Treatment Historic Market Size by Type (2016-2021)
4.2 Global Metabolic Disease Treatment Forecasted Market Size by Type (2022-2027)

5 Metabolic Disease Treatment Breakdown Data by Application
5.1 Global Metabolic Disease Treatment Historic Market Size by Application (2016-2021)
5.2 Global Metabolic Disease Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Metabolic Disease Treatment Market Size (2016-2027)
6.2 North America Metabolic Disease Treatment Market Size by Type
6.2.1 North America Metabolic Disease Treatment Market Size by Type (2016-2021)
6.2.2 North America Metabolic Disease Treatment Market Size by Type (2022-2027)
6.2.3 North America Metabolic Disease Treatment Market Size by Type (2016-2027)
6.3 North America Metabolic Disease Treatment Market Size by Application
6.3.1 North America Metabolic Disease Treatment Market Size by Application (2016-2021)
6.3.2 North America Metabolic Disease Treatment Market Size by Application (2022-2027)
6.3.3 North America Metabolic Disease Treatment Market Size by Application (2016-2027)
6.4 North America Metabolic Disease Treatment Market Size by Country
6.4.1 North America Metabolic Disease Treatment Market Size by Country (2016-2021)
6.4.2 North America Metabolic Disease Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Metabolic Disease Treatment Market Size (2016-2027)
7.2 Europe Metabolic Disease Treatment Market Size by Type
7.2.1 Europe Metabolic Disease Treatment Market Size by Type (2016-2021)
7.2.2 Europe Metabolic Disease Treatment Market Size by Type (2022-2027)
7.2.3 Europe Metabolic Disease Treatment Market Size by Type (2016-2027)
7.3 Europe Metabolic Disease Treatment Market Size by Application
7.3.1 Europe Metabolic Disease Treatment Market Size by Application (2016-2021)
7.3.2 Europe Metabolic Disease Treatment Market Size by Application (2022-2027)
7.3.3 Europe Metabolic Disease Treatment Market Size by Application (2016-2027)
7.4 Europe Metabolic Disease Treatment Market Size by Country
7.4.1 Europe Metabolic Disease Treatment Market Size by Country (2016-2021)
7.4.2 Europe Metabolic Disease Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Metabolic Disease Treatment Market Size (2016-2027)
8.2 Asia-Pacific Metabolic Disease Treatment Market Size by Type
8.2.1 Asia-Pacific Metabolic Disease Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Metabolic Disease Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Metabolic Disease Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Metabolic Disease Treatment Market Size by Application
8.3.1 Asia-Pacific Metabolic Disease Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Metabolic Disease Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Metabolic Disease Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Metabolic Disease Treatment Market Size by Region
8.4.1 Asia-Pacific Metabolic Disease Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Metabolic Disease Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Metabolic Disease Treatment Market Size (2016-2027)
9.2 Latin America Metabolic Disease Treatment Market Size by Type
9.2.1 Latin America Metabolic Disease Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Metabolic Disease Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Metabolic Disease Treatment Market Size by Type (2016-2027)
9.3 Latin America Metabolic Disease Treatment Market Size by Application
9.3.1 Latin America Metabolic Disease Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Metabolic Disease Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Metabolic Disease Treatment Market Size by Application (2016-2027)
9.4 Latin America Metabolic Disease Treatment Market Size by Country
9.4.1 Latin America Metabolic Disease Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Metabolic Disease Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Metabolic Disease Treatment Market Size (2016-2027)
10.2 Middle East & Africa Metabolic Disease Treatment Market Size by Type
10.2.1 Middle East & Africa Metabolic Disease Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Metabolic Disease Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Metabolic Disease Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Metabolic Disease Treatment Market Size by Application
10.3.1 Middle East & Africa Metabolic Disease Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Metabolic Disease Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Metabolic Disease Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Metabolic Disease Treatment Market Size by Country
10.4.1 Middle East & Africa Metabolic Disease Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Metabolic Disease Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Metabolic Disease Treatment Introduction
11.1.4 Merck Revenue in Metabolic Disease Treatment Business (2016-2021)
11.1.5 Merck Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Metabolic Disease Treatment Introduction
11.2.4 Novartis Revenue in Metabolic Disease Treatment Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Takeda Pharmaceutical
11.3.1 Takeda Pharmaceutical Company Details
11.3.2 Takeda Pharmaceutical Business Overview
11.3.3 Takeda Pharmaceutical Metabolic Disease Treatment Introduction
11.3.4 Takeda Pharmaceutical Revenue in Metabolic Disease Treatment Business (2016-2021)
11.3.5 Takeda Pharmaceutical Recent Development
11.4 Astra Zeneca
11.4.1 Astra Zeneca Company Details
11.4.2 Astra Zeneca Business Overview
11.4.3 Astra Zeneca Metabolic Disease Treatment Introduction
11.4.4 Astra Zeneca Revenue in Metabolic Disease Treatment Business (2016-2021)
11.4.5 Astra Zeneca Recent Development
11.5 Beohrigher Ingelheim
11.5.1 Beohrigher Ingelheim Company Details
11.5.2 Beohrigher Ingelheim Business Overview
11.5.3 Beohrigher Ingelheim Metabolic Disease Treatment Introduction
11.5.4 Beohrigher Ingelheim Revenue in Metabolic Disease Treatment Business (2016-2021)
11.5.5 Beohrigher Ingelheim Recent Development
11.6 KOWA
11.6.1 KOWA Company Details
11.6.2 KOWA Business Overview
11.6.3 KOWA Metabolic Disease Treatment Introduction
11.6.4 KOWA Revenue in Metabolic Disease Treatment Business (2016-2021)
11.6.5 KOWA Recent Development
11.7 Kythera
11.7.1 Kythera Company Details
11.7.2 Kythera Business Overview
11.7.3 Kythera Metabolic Disease Treatment Introduction
11.7.4 Kythera Revenue in Metabolic Disease Treatment Business (2016-2021)
11.7.5 Kythera Recent Development
11.8 Fuji yakuhin
11.8.1 Fuji yakuhin Company Details
11.8.2 Fuji yakuhin Business Overview
11.8.3 Fuji yakuhin Metabolic Disease Treatment Introduction
11.8.4 Fuji yakuhin Revenue in Metabolic Disease Treatment Business (2016-2021)
11.8.5 Fuji yakuhin Recent Development
11.9 LG Life Science
11.9.1 LG Life Science Company Details
11.9.2 LG Life Science Business Overview
11.9.3 LG Life Science Metabolic Disease Treatment Introduction
11.9.4 LG Life Science Revenue in Metabolic Disease Treatment Business (2016-2021)
11.9.5 LG Life Science Recent Development
11.10 Metsubishi Tanabe Pharma
11.10.1 Metsubishi Tanabe Pharma Company Details
11.10.2 Metsubishi Tanabe Pharma Business Overview
11.10.3 Metsubishi Tanabe Pharma Metabolic Disease Treatment Introduction
11.10.4 Metsubishi Tanabe Pharma Revenue in Metabolic Disease Treatment Business (2016-2021)
11.10.5 Metsubishi Tanabe Pharma Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details



【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 代謝性疾患治療の世界市場規模・現状・予測2021年-2027年(Global Metabolic Disease Treatment Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。